Brief: Cns Pharmaceuticals Says On July 5, Received Letter From Nasdaq Notifying Co It Had Regained Compliance With Bid Price Rule
09/07/2024 19:28
July 9 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS - ON JULY 5, RECEIVED LETTER FROM
NASDAQ
NOTIFYING CO THAT IT HAD REGAINED COMPLIANCE WITH BID PRICE RULE
Source text for Eikon: ID:n0001683168-24-004708
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026